Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313424574> ?p ?o ?g. }
- W4313424574 abstract "Abstract Background Patient reported outcome measures (PROM) can improve patient care and be crucial for symptom tracking especially during disease outbreaks. FLU-PRO Plus is a validated PROM used to track viral respiratory symptoms. Our study aimed to evaluate the feasibility of using FLU-PRO© Plus, to track symptoms across three healthcare systems. Methods The prospective, longitudinal study recruited adults between February-May 2021 from HealthPartners Institute (HP), Kaiser Permanente Georgia (KPGA), and Kaiser Permanente Mid-Atlantic States (KPMAS). Adult members were eligible if they had a positive lab or diagnosis for either COVID-19 or influenza-like illness (ILI) or exhibited 2 + viral respiratory symptoms. Descriptive statistics were calculated to describe the patient characteristics for participants that were eligible for FLU-PRO Plus, successfully contacted, attempted to log in to the FLU-PRO Plus website, and participants who completed FLU-PRO Plus Day 1. Bivariable and multivariable logistic regression using PROC GLIMMIXX investigated the patient characteristics associated with (1) successful contact and (2) FLU-PRO Plus Day 1 completion. Results We identified a total of 15,650 eligible participants during the enrollment period: 9,582 from HP, 1,740 from KPGA, and 4,328 from KPMAS. Among the total of 409 eligible adults who attempted to participate in FLU-PRO Plus, 317 completed FLU-PRO Plus Day 1. Among the 317 individuals that completed FLU-PRO Plus Day 1, 205 (67.5%) were diagnosed with COVID-19; 112 adults diagnosed with COVID-19 completed FLU-PRO Plus Day 14. Among adults successfully contacted, adults aged 35–64 (OR = 1.40, 95% CI 1.05, 1.87), females (OR = 1.77, 95% CI 1.38, 2.27), and adults diagnosed with COVID-19 (OR = 1.66, 95% CI 1.27, 2.17) had higher odds of completing FLU-PRO Plus Day 1; Asian adults (OR = 0.38, 95% CI 0.19, 0.76) and Black and African American adults (OR = 0.33, 95% CI 0.19, 0.76) had lower odds compared to White adults. Conclusion Our study reports on the feasibility of patients across three integrated healthcare systems utilizing FLU-PRO Plus to monitor their respiratory symptoms. Patient reported outcome measures (PROM) can improve patient care, quality of life, and reduce the strain of limited resources on healthcare systems. Future FLU-PRO Plus studies should develop an implementation strategy to fully integrate FLU-PRO Plus within clinical care and patient management." @default.
- W4313424574 created "2023-01-06" @default.
- W4313424574 creator A5002012389 @default.
- W4313424574 creator A5012344394 @default.
- W4313424574 creator A5032207355 @default.
- W4313424574 creator A5033771782 @default.
- W4313424574 creator A5047890864 @default.
- W4313424574 creator A5059432302 @default.
- W4313424574 creator A5064906759 @default.
- W4313424574 creator A5075543475 @default.
- W4313424574 creator A5077273505 @default.
- W4313424574 creator A5077466580 @default.
- W4313424574 creator A5077956170 @default.
- W4313424574 creator A5078768684 @default.
- W4313424574 creator A5081067039 @default.
- W4313424574 creator A5082815773 @default.
- W4313424574 date "2022-12-29" @default.
- W4313424574 modified "2023-10-16" @default.
- W4313424574 title "Systematic surveillance of patient-reported symptoms of viral respiratory tract infectious Syndromes in diverse populations" @default.
- W4313424574 cites W1513461128 @default.
- W4313424574 cites W1583909185 @default.
- W4313424574 cites W1971726757 @default.
- W4313424574 cites W2009781482 @default.
- W4313424574 cites W2046551315 @default.
- W4313424574 cites W2102223680 @default.
- W4313424574 cites W2137474323 @default.
- W4313424574 cites W2223575612 @default.
- W4313424574 cites W2263467157 @default.
- W4313424574 cites W2494153709 @default.
- W4313424574 cites W2563775695 @default.
- W4313424574 cites W2606041829 @default.
- W4313424574 cites W2622952143 @default.
- W4313424574 cites W2728794304 @default.
- W4313424574 cites W2753797655 @default.
- W4313424574 cites W2773736245 @default.
- W4313424574 cites W2782908833 @default.
- W4313424574 cites W2793922718 @default.
- W4313424574 cites W2801054072 @default.
- W4313424574 cites W2889300239 @default.
- W4313424574 cites W2891042955 @default.
- W4313424574 cites W2913465166 @default.
- W4313424574 cites W2914579361 @default.
- W4313424574 cites W2921335954 @default.
- W4313424574 cites W2923537290 @default.
- W4313424574 cites W2984564254 @default.
- W4313424574 cites W2997051538 @default.
- W4313424574 cites W2999160614 @default.
- W4313424574 cites W3012692193 @default.
- W4313424574 cites W3022622144 @default.
- W4313424574 cites W3023519397 @default.
- W4313424574 cites W3033399413 @default.
- W4313424574 cites W3040230595 @default.
- W4313424574 cites W3040977352 @default.
- W4313424574 cites W3094996005 @default.
- W4313424574 cites W3130067425 @default.
- W4313424574 cites W3130200679 @default.
- W4313424574 cites W3150048650 @default.
- W4313424574 cites W3164413356 @default.
- W4313424574 cites W3165912551 @default.
- W4313424574 cites W3167569123 @default.
- W4313424574 cites W3199898909 @default.
- W4313424574 cites W3200299601 @default.
- W4313424574 cites W3206700773 @default.
- W4313424574 cites W4207041895 @default.
- W4313424574 cites W4213075042 @default.
- W4313424574 doi "https://doi.org/10.1186/s12913-022-08991-3" @default.
- W4313424574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36581932" @default.
- W4313424574 hasPublicationYear "2022" @default.
- W4313424574 type Work @default.
- W4313424574 citedByCount "2" @default.
- W4313424574 countsByYear W43134245742023 @default.
- W4313424574 crossrefType "journal-article" @default.
- W4313424574 hasAuthorship W4313424574A5002012389 @default.
- W4313424574 hasAuthorship W4313424574A5012344394 @default.
- W4313424574 hasAuthorship W4313424574A5032207355 @default.
- W4313424574 hasAuthorship W4313424574A5033771782 @default.
- W4313424574 hasAuthorship W4313424574A5047890864 @default.
- W4313424574 hasAuthorship W4313424574A5059432302 @default.
- W4313424574 hasAuthorship W4313424574A5064906759 @default.
- W4313424574 hasAuthorship W4313424574A5075543475 @default.
- W4313424574 hasAuthorship W4313424574A5077273505 @default.
- W4313424574 hasAuthorship W4313424574A5077466580 @default.
- W4313424574 hasAuthorship W4313424574A5077956170 @default.
- W4313424574 hasAuthorship W4313424574A5078768684 @default.
- W4313424574 hasAuthorship W4313424574A5081067039 @default.
- W4313424574 hasAuthorship W4313424574A5082815773 @default.
- W4313424574 hasBestOaLocation W43134245741 @default.
- W4313424574 hasConcept C116675565 @default.
- W4313424574 hasConcept C126322002 @default.
- W4313424574 hasConcept C138816342 @default.
- W4313424574 hasConcept C142724271 @default.
- W4313424574 hasConcept C151956035 @default.
- W4313424574 hasConcept C159047783 @default.
- W4313424574 hasConcept C187212893 @default.
- W4313424574 hasConcept C188816634 @default.
- W4313424574 hasConcept C205545832 @default.
- W4313424574 hasConcept C2776012195 @default.
- W4313424574 hasConcept C534529494 @default.
- W4313424574 hasConcept C71924100 @default.
- W4313424574 hasConceptScore W4313424574C116675565 @default.